Long-acting reversible contraceptives: new evidence to support...
This Australia-based article provides a review of new LARC guidelines and of the use of a new lower dose IUD (19.5mg levonorgestrel). As with here, Australian GPs are a large access point for the population to contraception, including LARC. The uptake for IUDs has increased with the introduction of reimbursement...
Read more